与mRNA-1273的COVID-19疫苗接种者相比,对IgG2和IgG4的类切换在BNT162b2中更加明显
Alex S Siebner1, Johanna Griesbaum2, Kelsey E Huus3
1Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany; German Center for Infection Research, Partner Site Tübingen, Germany.
与mRNA-1273 (Moderna) 相比,用BNT162b2 (Pfizer/BioNTech) 进行的补充疫苗引发了较高的IgG2和IgG4抗体水平. 这些针对SARS-CoV-2疫苗的特殊差异可能会影响长期免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 接种SARS-CoV-2疫苗会产生抗体,这对于减少严重疾病至关重要.
- 不同的免疫球蛋白G (IgG) 亚类对补体激活,Fc受体结合和病毒中和具有不同的能力.
- 了解特定平台的IgG亚类反应对于评估疫苗疗效至关重要.
研究的目的:
- 为了比较BNT162b2与mRNA-1273.3接种后的IgG亚类反应,用BNT162b2对抗mRNA-1273.
- 调查先前疫苗接种史对后增剂IgG子类概况的影响.
主要方法:
- 一个多重免疫试验量化了IgG1,IgG2,IgG3和IgG4结合抗体对抗SARS-CoV-2抗原.
- 在接受了BNT162b2或mRNA-1273的增强剂后,从165名健康人群中采集了样本,这些人之前已经接种了两剂疫苗.
- 对抗体反应的特异性被分析为针对三聚体尖端蛋白,受体结合域和S1/S2子单元的特异性.
主要成果:
- 辅助疫苗接种增加了大多数IgG子类水平,但S1特异性IgG1和S2特异性IgG2.2的例外值得注意.
- 与mRNA-1273疫苗接种相比,在BNT162b2接种后观察到显著更高的IgG2和IgG4水平.
- 之前接受过非mRNA疫苗接种的个体在增强后IgG2或IgG4的水平没有显著增加.
结论:
- 在增剂接种疫苗后,在IgG子类反应中发现了明显的疫苗特异性差异.
- 这些变化可能会影响IgG2和IgG4之间的类切换.
- 在IgG子类的细微差异可能会影响长期免疫力和对SARS-CoV-2的保护.
更多相关视频
08:48Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
相关概念视频
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Humoral Immune Responses
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Leaky Scanning
